We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > influenza vaccines

News List

Seqirus Begins Shipping 2020/21 Influenza Vaccines to U.S. Market americanpharmaceuticalreview
August 06, 2020
Seqirus has begun shipping its portfolio of seasonal influenza vaccines to customers in the U.S. for the 2020/21 influenza season.
GSK Ships 2019-20 Seasonal Influenza Vaccines for US Market americanpharmaceuticalreview
July 17, 2019
GSK will begin shipping its quadrivalent influenza vaccines to US healthcare providers and pharmacies for the 2019-20 flu season, immediately following licensing and lot-release approval from the US Food and Drug Administration's (FDA) Center for Biologic
Influenza vaccines and drugs market to grow at CAGR of 10.24 per cent during 2017 to 2022 pharmaasia
July 19, 2017
The report to identify and analyse emerging trends along with major drivers, challenges and opportunities in the global influenza market. Also highlights key development and new drugs launched by various companies across the globe.
GSK ships 2017-18 seasonal influenza vaccines for US market cphi-online
July 18, 2017
Company expects to supply up to 40 million doses across both vaccines for the US market in the 2017-18 season.